DAX22.676 +1,6%ESt505.359 +0,9%Top 10 Crypto11,38 -1,1%Dow41.351 -0,2%Nas17.648 +1,2%Bitcoin77.210 +0,3%Euro1,0890 ±0,0%Öl70,85 -0,1%Gold2.939 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 Tesla A1CX3T NVIDIA 918422 PUMA 696960 HENSOLDT HAG000 NEL ASA A0B733 RENK RENK73 Siemens Energy ENER6Y Volkswagen (VW) vz. 766403 thyssenkrupp 750000 Amazon 906866 Eutelsat Communications A0HGPT Microsoft 870747 Apple 865985 Porsche PAG911
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX geht fest in den Feierabend -- Wall Street schließt uneinig -- Rheinmetall erhöht nach Gewinnsprung Dividende -- PUMA erwartet Gewinnrückgang -- Siemens Energy, Porsche, NEL, Plug Power im Fokus
Top News
Freundlicher Handel in New York: Börsianer lassen NASDAQ 100 zum Ende des Mittwochshandels steigen Freundlicher Handel in New York: Börsianer lassen NASDAQ 100 zum Ende des Mittwochshandels steigen
Gute Stimmung in New York: S&P 500 zum Ende des Mittwochshandels fester Gute Stimmung in New York: S&P 500 zum Ende des Mittwochshandels fester
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Endo Aktie

NeuKaufenVerkaufen
28,25 USD +0,15 USD +0,53 %
NASO
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Bei einem anderen Broker handelnSmartphone

Marktkap.1,97 Mrd. EUR

WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA40BSP

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS29290D1173

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolNDOI

Endo Aktien News

DatumMeistgelesen
PR NewswireEndo Announces Peyronie's Disease Presentation at the Annual Meeting of the Southeastern Section of the American Urological Association
PR NewswireEndo Announces Peyronie's Disease Presentation at the Annual Meeting of the Southeastern Section of the American Urological Association
PR NewswireEndo Announces Divestiture of International Pharmaceuticals Business
PR NewswireEndo Announces Divestiture of International Pharmaceuticals Business
PR NewswireEndo Announces Divestiture of International Pharmaceuticals Business
PR NewswireEndo Reschedules Release of Fourth Quarter and Full Year 2024 Earnings Results and Conference Call
PR NewswireEndo Reschedules Release of Fourth Quarter and Full Year 2024 Earnings Results and Conference Call
PR NewswireEndo Reschedules Release of Fourth Quarter and Full Year 2024 Earnings Results and Conference Call
PR NewswireEndo to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025
PR NewswireEndo to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025
PR NewswireEndo to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025
PR NewswireEndo Launches "Steve's Journey," the First Branded Dupuytren's Contracture Commercial for XIAFLEX® (collagenase clostridium histolyticum)
PR NewswireEndo Launches "Steve's Journey," the First Branded Dupuytren's Contracture Commercial for XIAFLEX® (collagenase clostridium histolyticum)
PR NewswireEndo Launches "Steve's Journey," the First Branded Dupuytren's Contracture Commercial for XIAFLEX® (collagenase clostridium histolyticum)
PR NewswireEndo Launches New Peyronie's Disease Campaign: I Got Somebody
PR NewswireEndo Announces Publication of Peyronie's Disease Self-Assessment Screening App Article in Peer-Reviewed Translational Andrology and Urology
PR NewswireEndo Announces Publication of Peyronie's Disease Self-Assessment Screening App Article in Peer-Reviewed Translational Andrology and Urology
PR NewswireEndo Announces Publication of Peyronie's Disease Self-Assessment Screening App Article in Peer-Reviewed Translational Andrology and Urology
PR NewswireEndo Launches Doxycycline for Injection, USP
PR NewswireEndo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
PR NewswireEndo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
PR NewswireEndo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
PR NewswireEndo Launches ADRENALIN® Ready-to-Use Premixed Bag, the First and Only FDA-Approved, Manufacturer-Prepared Epinephrine Premixed IV Bag
PR NewswireEndo Launches ADRENALIN® Ready-to-Use Premixed Bag, the First and Only FDA-Approved, Manufacturer-Prepared Epinephrine Premixed IV Bag
PR NewswireEndo Launches ADRENALIN® Ready-to-Use Premixed Bag, the First and Only FDA-Approved, Manufacturer-Prepared Epinephrine Premixed IV Bag
PR NewswireJohn Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and Treatment with XIAFLEX® (collagenase clostridium histolyticum)
PR NewswireJohn Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and Treatment with XIAFLEX® (collagenase clostridium histolyticum)
PR NewswireJohn Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and Treatment with XIAFLEX® (collagenase clostridium histolyticum)
PR NewswireEndo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling
PR NewswireEndo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada
PR NewswireEndo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada
PR NewswireEndo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada
PR NewswireEndo Reports Third-Quarter 2024 Financial Results and Reaffirms 2024 Financial Expectations
PR NewswireEndo Reports Third-Quarter 2024 Financial Results and Reaffirms 2024 Financial Expectations
PR NewswireEndo Reports Third-Quarter 2024 Financial Results and Reaffirms 2024 Financial Expectations
PR NewswireEndo Announces Successful Term Loan Repricing
PR NewswireEndo Announces Successful Term Loan Repricing
PR NewswireEndo Announces Successful Term Loan Repricing
PR NewswireEndo Presents Data at the American Society of Podiatric Surgeons (ASPS) Annual Surgical Conference
PR NewswireEndo Announces Seven New Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting
Wer­bung

Endo News

Endo News: auf dieser Seite finden Sie alle Endo News und Nachrichten zur Endo Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Endo News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Endo News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.